PD-L1 in pancreatic ductal adenocarcinoma: a retrospective analysis of 373 Chinese patients using an in vitro diagnostic assay

BACKGROUND: Programmed death ligand 1 (PD-L1) has shown potential as a therapeutic target in numerous solid tumors. Its prognostic significance has also been established in pancreatic ductal adenocarcinoma (PDAC). The present study aimed to explore PD-L1 expression in PDAC cases in a large Chinese c...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Xiaolong, Sun, Jian, Wu, Huanwen, Luo, Yufeng, Wang, Lili, Lu, Junliang, Zhang, Zhiwen, Guo, Junchao, Liang, Zhiyong, Liu, Tonghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389094/
https://www.ncbi.nlm.nih.gov/pubmed/29378617
http://dx.doi.org/10.1186/s13000-017-0678-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389094/
https://www.ncbi.nlm.nih.gov/pubmed/29378617
http://dx.doi.org/10.1186/s13000-017-0678-4

Ejemplares similares